These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 24909079

  • 21. Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis.
    Majewski MW, Cho S, Miller PA, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2015 Nov 01; 25(21):4933-4936. PubMed ID: 26037320
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.
    Kang S, Kim YM, Kim RY, Seo MJ, No Z, Nam K, Kim S, Kim J.
    Eur J Med Chem; 2017 Jan 05; 125():807-815. PubMed ID: 27750198
    [Abstract] [Full Text] [Related]

  • 23. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW, Tiwari R, Miller PA, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2068-71. PubMed ID: 26951749
    [Abstract] [Full Text] [Related]

  • 24. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
    Lu X, Tang J, Cui S, Wan B, Franzblauc SG, Zhang T, Zhang X, Ding K.
    Eur J Med Chem; 2017 Jan 05; 125():41-48. PubMed ID: 27654393
    [Abstract] [Full Text] [Related]

  • 25. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
    Bukowski L.
    Pharmazie; 2001 Jan 05; 56(1):23-7. PubMed ID: 11210662
    [Abstract] [Full Text] [Related]

  • 26. Antimycobacterial agents. 1. Thio analogues of purine.
    Pathak AK, Pathak V, Seitz LE, Suling WJ, Reynolds RC.
    J Med Chem; 2004 Jan 01; 47(1):273-6. PubMed ID: 14695841
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V, Maurya HK, Sharma S, Srivastava KK, Gupta A.
    Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2892-6. PubMed ID: 24835631
    [Abstract] [Full Text] [Related]

  • 28. Post Groebke-Blackburn multicomponent protocol: synthesis of new polyfunctional imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrimidine derivatives as potential antimicrobial agents.
    Al-Tel TH, Al-Qawasmeh RA.
    Eur J Med Chem; 2010 Dec 01; 45(12):5848-55. PubMed ID: 20934788
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and some reactions of 2-acetylimidazo[4,5-b]pyridine. Antituberculotic activity of the obtained compounds.
    Bukowski L, Janowiec M, Zwolska-Kwiek Z, Andrzejczyk Z.
    Pharmazie; 1999 Sep 01; 54(9):651-4. PubMed ID: 10522269
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and tuberculostatic activity of some derivatives of imidazo [4, 5-b]pyridine-1-carboxylic acid.
    Bukowski L.
    Pol J Pharmacol Pharm; 1984 Sep 01; 36(6):683-8. PubMed ID: 6442935
    [Abstract] [Full Text] [Related]

  • 31. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2016 Mar 15; 24(6):1298-307. PubMed ID: 26867485
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Patel H, Chaudhari K, Jain P, Surana S.
    Bioorg Chem; 2020 Sep 15; 102():104099. PubMed ID: 32711084
    [Abstract] [Full Text] [Related]

  • 33. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S, Kim RY, Seo MJ, Lee S, Kim YM, Seo M, Seo JJ, Ko Y, Choi I, Jang J, Nam J, Park S, Kang H, Kim HJ, Kim J, Ahn S, Pethe K, Nam K, No Z, Kim J.
    J Med Chem; 2014 Jun 26; 57(12):5293-305. PubMed ID: 24870926
    [Abstract] [Full Text] [Related]

  • 34. New imidazo [4,5-b]pyridine carboxylic acids and their derivatives with expected tuberculostatic activity.
    Bukowski L, Janowiec M.
    Pharmazie; 1988 May 26; 43(5):315-7. PubMed ID: 3140255
    [No Abstract] [Full Text] [Related]

  • 35. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Sajja Y, Vanguru S, Vulupala HR, Nagarapu L, Perumal Y, Sriram D, Nanubolu JB.
    Chem Biol Drug Des; 2017 Oct 26; 90(4):496-500. PubMed ID: 28267891
    [Abstract] [Full Text] [Related]

  • 36. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
    Ranft D, Lehwark-Yvetot G, Schaper KJ, Büge A.
    Arch Pharm (Weinheim); 1997 Jun 26; 330(6):169-72. PubMed ID: 9297448
    [Abstract] [Full Text] [Related]

  • 37. Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives.
    Kasimogullari BO, Cesur Z.
    Molecules; 2004 Sep 30; 9(10):894-901. PubMed ID: 18007490
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and S(N)(H) reactions.
    Kravchenko MA, Verbitskiy EV, Medvinskiy ID, Rusinov GL, Charushin VN.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3118-20. PubMed ID: 24856062
    [Abstract] [Full Text] [Related]

  • 39. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
    Shelke RU, Degani MS, Raju A, Ray MK, Rajan MG.
    Arch Pharm (Weinheim); 2016 Aug 15; 349(8):602-13. PubMed ID: 27320965
    [Abstract] [Full Text] [Related]

  • 40. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold.
    Jones ED, Vandegraaff N, Le G, Choi N, Issa W, Macfarlane K, Thienthong N, Winfield LJ, Coates JA, Lu L, Li X, Feng X, Yu C, Rhodes DI, Deadman JJ.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5913-7. PubMed ID: 20727748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.